Does anyone know about Jiangsu Yunyang Pharmaceutical?

Jiangsu Yunyang Group Pharmaceutical Co., Ltd. Jiangsu Yunyang Group Pharmaceutical Co., Ltd. is located in Danyang City, Shanghai, an ancient city in the south of the Yangtze River with outstanding people, beautiful scenery and known as the "City of Cultural Relics in the South of the Yangtze River". The Nanjing-Nanjing Railway, Shanghai-Nanjing Expressway, Beijing-Hangzhou Grand Canal, National Highway 312 and other water and land passages run through the entire territory. Changzhou Airport is located on the outskirts of the city, with convenient transportation, developed economy and beautiful environment. Formerly known as the state-owned enterprise Danyang Pharmaceutical Factory, it was founded in September 1974. It has now become a pharmaceutical enterprise of considerable scale integrating scientific research, production and sales, mainly producing Western medicine preparations and also producing raw materials and Chinese patent medicines. . The company currently has production workshops for synthesis, tablets, eye drops, nasal drops, tinctures, and proprietary Chinese medicines, with nearly 90 product varieties. Clotrimazole API was developed in 1984, with an annual production capacity of 100 tons, a domestic market share of more than 60%, and is exported to Southeast Asia and Eastern European countries. Clonidine hydrochloride (raw materials, tablets) has a domestic market share of over 90%. The Chinese patent medicine Zhenju Antihypertensive Tablets has been favored by users due to its obvious antihypertensive effect, no toxic side effects, and popular price, and its sales volume has doubled year by year. In recent years, our company has continuously increased its efforts in product innovation, and national-level new drugs Yumei Tablet (new antitussive drug) and Meloxicam (raw materials and tablets, used to treat rheumatism) have been officially launched on the market. Zijin Gantai Capsules and Yishen Shengxue Tablets, new Class III traditional Chinese medicines, have obtained clinical approval.